TheEdgeResearch
Home / Stocks / EVRC

Evercel, Inc. (EVRC)

OTC Industrials Industrial - Machinery
$0.35 ▼ -0.00%
Market Cap
$11.4M
Sector
Industrials
Industry
Industrial - Machinery
Beta
-0.25
52-Wk Range
0.1-0.74
CEO
John S. Weinberg
Country
US
Currency
USD

Evercel, Inc. operates in the Industrial - Machinery industry of the Industrials sector, headquartered in Miami, FL, US. The stock last traded at $0.35, down 0.00% on the session, giving a market capitalisation of $11.4M. On trailing twelve-month figures it carries a trailing P/E of 7.29, a net margin of 2.1%. Its beta of -0.25 implies it has historically moved less than the broad market.

Valuation & profitability (TTM)
P/E
7.29
Price / Sales
0.15
Price / Book
0.16
EV / EBITDA
-295.15
Gross margin
38.6%
Operating margin
5.7%
Net margin
2.1%
Return on equity
Debt / equity
1.68
Current ratio
2.03
Dividend yield
0.0%
Payout ratio
0.0%
Company profile
Exchange
Other OTC
Employees
2,215
IPO date
1999-04-07
Headquarters
Miami, FL, US
About Evercel, Inc.

Evercel, Inc., through its interest in Printronix Holding Corporation, designs and manufactures printers and related consumables for various industrial printing applications worldwide. The company provides multi-technology supply chain printing solutions for various industries, including manufacturing, transportation and logistics, retail distribution, food and beverages distribution, and pharmaceutical distribution. Its line matrix printers are used in various applications, such as labeling and inventory management, build sheets, invoicing, manifests and bills of lading, and reporting. The company offers its products directly to end-users, as well as through channel partners, such as dealers and distributors. Evercel, Inc. was incorporated in 1998 and is based in Miami, Florida.

Comparable companies

Evercel, Inc. is most often compared with the following Industrials names:

AITXDDDIEHCLOGIMFCOMHTXORBTPSPRSVIDE
More research on EVRC
EVRC technical analysis EVRC TheEdge Score Compare against peers
Open full interactive analysis & DCF →